What Arrow Diagnostics does

Arrow Diagnostics S.r.l. is an Italian molecular diagnostics distribution company headquartered in Genoa, founded in 2003 and operating as a wholly-owned subsidiary subject to the direction and coordination (direzione e coordinamento) of Seegene Inc., a South Korean molecular diagnostics group. The company is the exclusive Italian commercial arm of Seegene, distributing multiplex Real-Time PCR kits (Allplex, Anyplex, Novaplex brands), isothermal LAMP rapid tests (eazyplex), NGS solutions (AD4Seq, CleanPlex, Deeplex), rapid immunochromatographic tests (FREND), and fully automated instrumentation (Seegene STARlet, Seegene Nimbus, FACIS). The portfolio spans syndromic infectious disease testing (respiratory, gastrointestinal, STI, meningitis, antimicrobial resistance, mycobacteria, HPV, mycology), HIV drug resistance NGS, oncology (MammaTyper, MYELOID SOLUTION), and microbiome analysis.

Arrow Diagnostics generates revenue through the B2B sale of molecular diagnostic reagents, kits, and instrumentation to clinical hospital laboratories and public health institutions across Italy, supported by direct field sales coverage of Northern, Central, and Southern Italy and the major islands, plus regional technical representatives and applications support. Products are CE-IVD and IVDR-compliant where certified, with quote-based commercial terms and pricing not publicly disclosed. The company engages customers through scientific congresses (AMCLI, SIM, SIGU), peer-reviewed publications, technical webinars, and an Italian-language website providing IFU, SDS, and SSP documentation. Customer logos include hospital laboratories (e.g., Ospedale A.R.N.A.S. Civico di Cristina Benfratelli di Palermo, MATER OLBIA Hospital) and government/public bodies (ASL1 Imperiese, Lega Navale Italiana), with COVID-era event testing (Sanremo 2021, World Triathlon Cup, HANSA World Championship) representing episodic rather than recurring anchor revenue.

The company's strategic positioning is as a regulatory- and technically-capable local distributor that converts Seegene's global product cadence into Italy-specific clinical adoption, while coordinating Italian participation in parent-level initiatives including the Seegene-Microsoft AI collaboration, the Springer Nature Open Innovation Program, and the Werfen-Seegene technology-sharing JV. No independent venture capital, private equity investment, or public listing has been identified; the entity is fully owned and operated under Seegene's strategic direction.

Name

Arrow Diagnostics

Legal name

Arrow Diagnostics S.r.l.

Website

https://arrowdiagnostics.it

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Arrow Diagnostics is the exclusive Italian distribution subsidiary of Seegene Inc., selling multiplex PCR kits, isothermal LAMP rapid tests, NGS solutions, and automation to clinical hospital laboratories and public health institutions across Italy.

Ownership category

akta.pro rank

Product category

Clinical Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Molecular diagnostics distribution
• Multiplex real-time PCR
• Isothermal amplification tests
• Clinical microbiology reagents
• Next generation sequencing kits

Headquarters

HQ city

Genoa

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Molecular Diagnostic Reagents and Kits: Arrow Diagnostics generates revenue through the sale of molecular diagnostic reagents, PCR kits, and rapid test products to clinical laboratories, hospitals, and healthcare facilities in Italy. Products are sold directly to healthcare institutions with technical support services included.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Arrow Diagnostics distributes and provides technical support for molecular diagnostic reagents, kits, and automated instrumentation in Italy on behalf of Seegene Inc. and other international diagnostic technology partners. Its core offering is a portfolio of multiplex Real-Time PCR assays (Allplex™, Anyplex™, Novaplex™), isothermal LAMP rapid tests (eazyplex®), NGS-based panels (AD4Seq, CleanPlex®, Deeplex®), chemiluminescence immunoassays, and supporting automated systems, sold directly to clinical hospital laboratories, public health labs, and healthcare facilities.

Product overview

Arrow Diagnostics distributes molecular diagnostic solutions for microbiology, oncology, genetics, rapid testing, and instrumentation. The product portfolio centers on multiplex Real-Time PCR (Allplex™ and Anyplex™ brands) and isothermal LAMP tests (eazyplex® brand) for syndromic infectious disease detection, covering respiratory infections, gastrointestinal infections, sexually transmitted infections, meningitis, antimicrobial resistance, mycobacteria, HIV, HPV, and fungal diseases. Additional offerings include rapid lateral flow tests (FREND™), fully automated systems (FACIS), Next Generation Sequencing solutions (AD4Seq, CleanPlex®, Deeplex®), oncology diagnostics (MammaTyper®, MYELOID SOLUTION™), and microbiome analysis. The company operates under direction and coordination of Seegene Inc. (Korea) and distributes internationally-developed diagnostic technologies in Italy.

Differentiator

Problem solved

Functional benefit

Products and services

• Allplex™ Respiratory Full Panel Assay One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 26 respiratory pathogens (16 viruses, 7 bacteria, 3 Flu A subtypes) for clinical microbiology laboratories performing respiratory infection diagnosis.
• Allplex™ Gastrointestinal Full Panel Assay One-step RT Real-Time PCR multiplex assay for simultaneous detection of 25 gastrointestinal pathogens (6 viruses, 13 bacteria, 6 parasites) across 4 diagnostic panels for hospital laboratories diagnosing gastroenteritis.
• Allplex™ STI/BV Panel Assay Real-Time PCR multiplex assay for simultaneous detection of 28 pathogens (16 bacteria, 7 fungi, 4 viruses, 1 parasite) causing sexually transmitted infections and bacterial vaginosis, targeted at clinical microbiology and STI clinics.
• Anyplex™ II HPV HR Detection Multiplex Real-Time PCR assay for simultaneous detection of 14 high-risk HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) validated for cervical cancer primary screening; CE-IVD marked.
• Anyplex™ II HPV28 Detection Multiplex Real-Time PCR for simultaneous detection, differentiation, and semiquantification of 28 HPV genotypes (19 high-risk, 9 low-risk) using DPO™ and TOCE™ technologies, for clinical laboratories running HPV genotyping.
• Allplex™ Meningitis Panel Assays One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 18 meningitis pathogens (6 bacteria and 12 viruses) for hospital microbiology labs.
• Allplex™ Entero-DR Assay Real-Time PCR multiplex assay for simultaneous detection and identification of 8 antimicrobial resistance genes (carbapenemases, ESBL, AmpC β-lactamases) for clinical microbiology labs performing antimicrobial resistance surveillance.
• Anyplex™ MTB/NTM & Anyplex™ MTB/NTMe Real-Time Detection Real-Time PCR assays for detection of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria (NTM), including drug resistance detection variants, for hospital tuberculosis laboratories.
• Allplex™ MG & AziR Assay Real-Time PCR for detection of Mycoplasma genitalium and macrolide resistance mutations, used by hospital microbiology and STI laboratories.
• Allplex™ MG & MoxiR Assay Real-Time PCR for detection of Mycoplasma genitalium and fluoroquinolone resistance mutations, for STI and microbiology laboratories.
• HIV-1 Solution v2 NGS-based analysis for detection of drug resistance mutations in HIV-1 across RT, protease, integrase, and gp120 regions; IVDR certified under Reg. EU 2017/746, targeted at reference laboratories.
• Goldstream Fungus (1-3)-β-D-Glucan Test Chromogenic quantitative detection of (1-3)-β-D-Glucan fungal antigen in serum and bronchoalveolar lavage for diagnosis of invasive fungal infections in hospital laboratories.
• FungiXpert® Aspergillus Galactomannan Detection Kit CLIA (chemiluminescence) and LFA tests for rapid detection of Aspergillus galactomannan antigen for invasive aspergillosis diagnosis in hospital microbiology laboratories.
• FungiXpert® Fungus (1-3)-β-D-Glucan Detection Kit CLIA-based detection kit for fungal (1-3)-β-D-Glucan antigen for diagnosis of invasive fungal infections.
• GeneProof Aspergillus PCR Kit Multiplex Real-Time PCR for simultaneous detection and differentiation of Aspergillus spp and Aspergillus terreus in blood, plasma, BAL, and sputum samples for hospital microbiology laboratories.
• eazyplex® SuperBug CRE LAMP isothermal rapid test for detection of carbapenemase-producing Enterobacteriaceae (CRE) in approximately 30 minutes without DNA extraction, used by hospital microbiology labs for infection control.
• eazyplex® MRSA/MRSAplus LAMP isothermal rapid test for detection of methicillin-resistant Staphylococcus aureus (MRSA) including PVL genes in approximately 30 minutes without DNA extraction, for infection control and hospital microbiology use.
• eazyplex® CSF direct LAMP isothermal rapid test for bacterial and viral meningitis diagnosis in 30 minutes without DNA/RNA extraction, used by hospital laboratories.
• eazyplex® VRE LAMP isothermal rapid test for vancomycin-resistant Enterococcus (VRE) detection, used for infection control in hospital settings.
• eazyplex® Candida auris LAMP isothermal rapid test for Candida auris skin colonization detection for hospital infection control and screening programs.
• eazyplex® SARS-CoV-2 LAMP isothermal rapid test for SARS-CoV-2 detection for hospital and point-of-care COVID-19 diagnostics.
• eazyplex® Pneumocystis jiroveci LAMP isothermal rapid test for Pneumocystis jiroveci detection for hospital microbiology laboratories diagnosing PCP pneumonia.
• eazyplex® StrepB LAMP isothermal rapid test for Streptococcus agalactiae (Group B Strep) detection in less than 30 minutes without DNA extraction, for intrapartum screening in hospitals and maternity wards.
• FREND™ COVID-19 Ag Microfluidic lateral flow immunochromatographic rapid test for qualitative detection of SARS-CoV-2 nucleocapsid antigen in 3 minutes, used by hospitals and event organizers for rapid screening.
• FACIS (Full-Automatic Chemiluminescence Immunoassay System) Fully automated chemiluminescence immunoassay system for rapid and fully automatic diagnosis of invasive fungal infections in hospital microbiology laboratories.
• AD4Seq Next Generation Sequencing (NGS) solution for advanced microbiological diagnostics including comprehensive pathogen identification and genomic analysis for hospital microbiology and reference laboratories.
• CleanPlex® SARS-CoV-2 Panel NGS panel for complete genome sequencing of SARS-CoV-2 for research and surveillance use in reference and public health laboratories.
• Deeplex® Myc-TB Targeted NGS for comprehensive identification of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria with drug resistance profiling, for hospital and reference TB laboratories.
• Microbiota solution A / Microbiota solution B NGS-based bacterial microbiota characterization solutions with automatic result interpretation for clinical and research laboratories.
• MammaTyper® Real-Time PCR-based breast cancer biomarker quantification assay (MammaTyper®) for molecular subtyping of breast cancer in hospital pathology laboratories.
• MYELOID SOLUTION™ BY SOPHiA GENETICS NGS-based solution for myeloid cancer analysis and mutation profiling in myelodysplastic syndromes, used by hospital oncology and reference laboratories.
• Novaplex™ MPXV/OPXV Assay Multiplex Real-Time PCR assay for simultaneous detection of Monkeypox virus (MPXV) and other orthopoxviruses, used by hospital and reference microbiology laboratories.
• Novaplex™ Tropical fever virus Assay (RUO) Multiplex PCR for detection of tropical fever-causing viruses (Research Use Only) for hospital and reference laboratories.
• Allplex™ GI-Parasite Assay Multiplex Real-Time PCR for diagnosis of intestinal protozoa in stool samples for hospital microbiology laboratories.
• Allplex™ GI-Helminth(I) Assay Multiplex Real-Time PCR for detection of intestinal helminths in stool samples for hospital microbiology laboratories.
• Allplex™ GI-Bacteria(I) Assay Multiplex Real-Time PCR for detection of gastrointestinal bacteria in stool samples for hospital microbiology laboratories.
• Allplex™ RV Essential Assay Real-Time PCR assay for essential respiratory virus detection for hospital clinical laboratories.
• Anyplex™ II STI-7e Detection Real-Time PCR assay for detection of 7 sexually transmitted infection pathogens for hospital microbiology and STI clinics.
• Allplex™ PneumoBacter Assay Real-Time PCR for detection of Streptococcus pneumoniae and other respiratory bacterial pathogens in hospital microbiology laboratories.
• Allplex™ Dermatophyte Assay (RUO) Real-Time PCR assay for dermatophyte detection (Research Use Only) for hospital mycology laboratories.

Quantifiable outcome

• Tests demonstrated 100% sensitivity and 100% specificity in FIND evaluation studies

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core, flagship and major.

• WerfencoreStrategic or Co-development Partner · 18 October 2024Seegene and Werfen finalized a partnership agreement for a technological sharing initiative. Under the agreement, Seegene and Werfen will establish NewCo Werfen-Seegene in Spain, following completion of required government approvals expected within the first half of 2025. This joint venture represents a significant strategic alliance in the in vitro diagnostics market.
• Springer NatureflagshipStrategic or Co-development Partner · 23 May 2024Seegene and Springer Nature announced a strategic alliance as part of the Open Innovation Program to promote collaboration with researchers working in various fields of medicine using the best PCR diagnostic technologies. This is a flagship initiative under the OneSystem Business model.
• Seegene Inc.coreTechnology or IntegrationSeegene Inc. (Korea) is the parent company and primary technology provider for Arrow Diagnostics. The company is subject to direction and coordination of Seegene Inc. Arrow Diagnostics distributes Seegene's comprehensive portfolio of multiplex molecular diagnostic products including Allplex, Anyplex, Novaplex, and eazyplex brands in Italy. Seegene provides advanced technologies including DPO (Dual Priming Oligonucleotide) and TOCE (Temperature Oligonucleotide Chip Enumeration) platforms.
• Seegene Inc.coreStrategic or Co-development PartnerArrow Diagnostics operates as the exclusive Italian subsidiary and commercial arm of Seegene Inc. in Italy, coordinating the Open Innovation Program with Springer Nature, participating in the OneSystem Business initiative, and representing Seegene's technological sharing initiatives including the partnership with Werfen.
• IlluminamajorTechnology or IntegrationIllumina is listed as a technology partner providing NGS (Next Generation Sequencing) platforms and technologies that Arrow Diagnostics integrates with its molecular diagnostic solutions, particularly for advanced genomic applications.
• Sophia GeneticsmajorTechnology or IntegrationSophia Genetics is a technology partner providing NGS-based solutions including the MYELOID SOLUTION for hematological diagnostics and CleanPlex powered by SOPHiA technology that Arrow Diagnostics distributes in Italy.

Scale indicators2 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• bioMérieux: Global in vitro diagnostics company headquartered in France with strong leadership in clinical microbiology. Comparable as a multinational IVD incumbent whose BioFire multiplex panels and microbiology products directly compete with Arrow's offerings in Italian hospital labs.
• DiaSorin: Italian-headquartered global IVD company (Saluggia) with a broad portfolio spanning immunoassays, molecular diagnostics, and specialty testing. Comparable as a much larger Italian-listed IVD incumbent serving similar clinical laboratory customers, though operating globally with a wider product portfolio.
• QIAGEN: Global molecular diagnostics and sample technologies company with a broad PCR and syndromic testing portfolio. Comparable as a major multinational IVD player whose QIAstat-Dx respiratory panel and other molecular products directly overlap with Arrow's syndromic test offerings in Italy.
• Cepheid (Danaher): Global molecular diagnostics leader (now part of Danaher) with the GeneXpert system and extensive infectious disease test menu. Comparable as a multinational IVD incumbent whose molecular diagnostic platform directly competes with Arrow's PCR offerings in Italian hospital laboratories.
• Copan Diagnostics: Italian-headquartered company (Brescia) specializing in pre-analytical specimen collection and processing, with growing molecular diagnostics capabilities. Comparable as a larger Italian diagnostics player with overlapping clinical laboratory customers in the microbiology workflow.
• Hologic: Global molecular diagnostics company with the Panther system and broad infectious disease test menu. Comparable as a multinational IVD player with a multiplex molecular diagnostics portfolio directly overlapping Arrow's syndromic panel offerings in Italian hospital labs.

Others

• Seegene Inc. South Korean parent company and primary technology provider for Arrow Diagnostics. Included as the upstream supplier whose product portfolio, R&D pipeline, and strategic decisions (including the Werfen-Seegene NewCo and Microsoft AI collaboration) directly determine Arrow's product roadmap and growth trajectory.

Direct peers

• AB Analitica: Italian in vitro diagnostics company headquartered in Padova that manufactures and distributes a wide range of clinical diagnostics products including molecular biology reagents. Comparable as an Italian IVD distributor serving clinical hospital laboratories with a similar product breadth and B2B sales model.
• Diatech Pharmacogenetics: Italian molecular diagnostics company based in Jesi that develops and distributes real-time PCR kits for pharmacogenetics, oncology, and infectious diseases. Directly comparable as another Italy-based molecular diagnostics distributor with a comparable scale, customer base of clinical laboratories, and product portfolio overlap in infectious disease and oncology.
• GeneticLab: Italian molecular diagnostics company providing PCR and genetic testing services and reagents to Italian clinical laboratories. Comparable as a domestic Italian molecular diagnostics player serving overlapping clinical microbiology and genetics customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arrow Diagnostics